News Releases 2017

RSS

12 OCT 2017 Pharmaceuticals
Otsuka and Lundbeck Announce Initiation of Two Phase 3 Trials of Brexpiprazole in Patients with Bipolar I Disorder
10 OCT 2017 Nutraceuticals
Otsuka Pharmaceutical Enters into Comprehensive Partnership with Kochi Prefecture
13 SEP 2017 Nutraceuticals
Otsuka Pharmaceutical Enters Into Health Promotion Partnership with Ehime Prefecture
24 AUG 2017 Pharmaceuticals
Otsuka and Mylan Announce License Agreement to Commercialize Delamanid (DeltybaTM) for Multidrug-Resistant Tuberculosis (MDR-TB) in High-Burden Countries
21 AUG 2017 Nutraceuticals
Extremely Fine-textured Foam Facial Cleanser
Introducing UL•OS Face Wash for Skin Care
Evolution of Face Wash from “Cleansing” to “Skin Care”
15 AUG 2017 Corporate
Otsuka Pharmaceutical Participates in Summer Events in Tokushima
Exciting Summer in WAJIKI, Tokushima Awa Odori,
Oronamin C Drink Presents Awa Odori Sound Festival
29 JUL 2017 Pharmaceuticals
ABILIFY MAINTENA® (aripiprazole) for Extended-Release Injectable Suspension Approved by U.S. FDA for Maintenance Monotherapy Treatment of Bipolar I Disorder
28 JUL 2017 Pharmaceuticals
Otsuka Submits New Drug Application in Japan for Aripiprazole Sertraline Combination Tablets
27 JUL 2017 Nutraceuticals
Otsuka Pharmaceutical to Acquire Daiya,
a Rapidly Growing Plant-Based Food Company in North America

Go to the Top

Go to the Top

Go to the Top

Go to the Top

Go to the Top